Catalpol Confers Neuroprotection against Cerebral Ischemic Injury by Regulating the Phosphatidylinositol 3-Kinase/Protein Kinase B/Glycogen Synthase Kinase 3 Beta/β-Catenin Signaling PathwayOA
Catalpol Confers Neuroprotection against Cerebral Ischemic Injury by Regulating the Phosphatidylinositol 3-Kinase/Protein Kinase B/Glycogen Synthase Kinase 3 Beta/β-Catenin Signaling Pathway
Xiao-Yu Zheng;Zi-Yan Wang;Ying Li;Jian-Xun Liu;Gui-Yue Wang;Hong-Wei Zhang;Xian Zhou;Wen-Ting Song;Zi-Shan Huang;Ye-Hao Zhang;Ming-Jiang Yao;Feng Li
Beijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaNational Clinical Research Center for Chinese Medicine Cardiology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,Beijing,ChinaNICM Health Research Institute,Western Sydney University,Westmead,NSW,AustraliaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,China||Research Institute of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,ChinaBeijing Key Laboratory of Traditional Chinese Medicine Pharmacology,Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,National Research Center for Clinical Medicine of Cardiovascular Diseases of Traditional Chinese Medicine,Beijing,China
Catalpolischemic strokeneuronal apoptosisneuroprotectionphosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta/β-catenin signaling pathway
Catalpolischemic strokeneuronal apoptosisneuroprotectionphosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta/β-catenin signaling pathway
《世界中医药杂志（英文版）》 2026 (2)
195-210,16
This research was supported by the National Natural Science Foundation of China(No.82030124).
评论